# DR Reddy'S Laboratories, Inc.

Canonical: https://abierto.us/vendors/dr-reddy-s-laboratories-inc-e8d8b9f7j3t5

- UEI: E8D8B9F7J3T5
- CAGE: 4E8M8
- Parent: Dr.Reddy'S Laboratories Limited
- Location: Princeton, NJ
- Awards in window: 9 (84 transactions), $0 obligated, January 18, 2024 to September 1, 2026

## Awarding agencies

- Department of Veterans Affairs: 9 awards, $0

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: $0

## Competition

- Full and Open Competition: 9 awards

## Solicitations won

- Metoprolol Succinate Tablets SA April 29, 2026 - April 28, 2027 (36E79725R0058), $34,174,868. https://abierto.us/opportunities/36e79725r0058
- Colchicine Tablets Base Year Ordering Period: 10/15/2025 - 10/14/2026 (36E79725R0034), $4,752,960. https://abierto.us/opportunities/36e79725r0034

## Largest awards

- 36E79720D0069: $0, Nac Pharmaceuticals. Incorporate NDC Changes for Clonidine Patches as a Result of Novation from Mayne Pharma to Dr. Reddy'S Laboratories.. https://www.usaspending.gov/award/CONT_IDV_36E79720D0069_3600/
- 36E79721D0017: $0, Nac Pharmaceuticals. Update to Cost Recovery Fee and Submission of Quarterly Sales Reports.. https://www.usaspending.gov/award/CONT_IDV_36E79721D0017_3600/
- 36E79721D0050: $0, Nac Pharmaceuticals. Update to Cost Recovery Fee (Crf) and Submission of Quarterly Sales Reports.. https://www.usaspending.gov/award/CONT_IDV_36E79721D0050_3600/
- 36E79722D0020: $0, Nac Pharmaceuticals. This Modification Is Issued to Incorporate Dr. Reddy'S Laboratories 2025 Subcontracting Plan Effective for the Period of April 1, 2024 - March 31, 2025. https://www.usaspending.gov/award/CONT_IDV_36E79722D0020_3600/
- 36E79722D0031: $0, Nac Pharmaceuticals. Cost Recovery Fee Change Mod. https://www.usaspending.gov/award/CONT_IDV_36E79722D0031_3600/
- 36E79723D0003: $0, Nac Pharmaceuticals. Exercise Option 1.. https://www.usaspending.gov/award/CONT_IDV_36E79723D0003_3600/
- 36E79725D0050: $0, Nac Pharmaceuticals. Award to Dr. Reddy'S Laboratories, INC. for Colchicine 0.6MG Tablets for Base Year with Four One Year Options.. https://www.usaspending.gov/award/CONT_IDV_36E79725D0050_3600/
- 36E79726D0011: $0, Nac Pharmaceuticals. New Award for Metoprolol Succinate Tablets with Dr. Reddys Laboratories. Ordering Period Is April 29, 2026 to April 28, 2027 with Four ON-YEAR Options.. https://www.usaspending.gov/award/CONT_IDV_36E79726D0011_3600/
- 36F79720D0232: $0, Nac Federal Supply Schedule. Product Deletions. https://www.usaspending.gov/award/CONT_IDV_36F79720D0232_3600/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/dr-reddy-s-laboratories-inc-e8d8b9f7j3t5.